AI-generated summary
The authors studied the EA.hy926 human endothelial cell line exposed to TNF-α plus cycloheximide to induce apoptosis, then tested low-level laser therapy at 660 nm. They report that the light reduced apoptosis and caspase activation and suppressed p38 MAPK signaling, with the effect appearing to depend on p38 suppression. These are cell-culture findings, so they do not establish effects in people.
- Who or what was studied
- Human endothelial cell line EA.hy926 (cell culture, not human participants)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used a single cell line in laboratory culture rather than human or animal subjects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation, Wound healing, Nitric oxide. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.